Skip to content
Screener

Bausch + Lomb BLCO Vision Care — Total revenues

Other segment segments

Pharmaceuticals
$300M+15.4%
Surgical
$256M+18.5%

Similar metrics at other companies

TBR
TBRGPatient Care — Total revenues
$33M+6.2%
PBH
PBHOral Care — Total revenues
$22.36M+3.0%
Mirion Technologies logo
MIRCancer care — Total revenues
$62.8M+1.0%
ALN
ALNYTotal Rare — Total revenues
$141.89M+11.1%
PBH
PBHEye & Ear Care — Total revenues
$32.98M+2.1%
PK
PKCore Hotels — Total revenues
$560M+6.7%

Other financials

Income statement

See full
Revenue$1.4B+9.1%
Operating income$83.0M+855%
Net income-$14.0M+77.4%
EPS (diluted)-$0.04+77.8%

Balance sheet

See full
Cash & equivalents$378.0M+39.0%
Total debt$5.1B+2.4%
Total equity$6.4B-1.0%
Total assets$13.9B+0.2%

Cash flow

See full
Operating cash flow$153.0M+337%
CapEx$71.0M-20.2%
Free cash flow$82.0M+252%

Valuation

See full
Market cap$5.84B+17.0%
Enterprise value$10.54B+8.9%
P/S1.1×+0.1×

Profitability

See full
Operating margin6.1%+5.3pp
Net margin-3.2%-1.0pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-2.7%-0.7pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001860742-26-000088
(in millions)Vision Care / Three Months Ended June 30, 2026Vision Care / Three Months Ended June 30, 2025Pharmaceuticals / Three Months Ended June 30, 2026Pharmaceuticals / Three Months Ended June 30, 2025Surgical / Three Months Ended June 30, 2026Surgical / Three Months Ended June 30, 2025Total / Three Months Ended June 30, 2026Total / Three Months Ended June 30, 2025
Revenues
Product Sales$781$751$354$307$254$214$1,389$1,272
Other Revenues3222256
7847533543092562161,3941,278
Expenses
Cost of goods sold (excluding amortization and impairments of intangible assets)29129089104147129
Cost of other revenues2
Selling, general and administrative2472431491548073

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch + Lomb's vision care — total revenues?
Bausch + Lomb (BLCO) reported vision care — total revenues of $784M in Q2 2026.
How has Bausch + Lomb's vision care — total revenues changed year-over-year?
Bausch + Lomb's vision care — total revenues increased by 4.1% year-over-year, from $753M to $784M.
What is the long-term trend for Bausch + Lomb's vision care — total revenues?
Over 4 years (2021 to 2025), Bausch + Lomb's vision care — total revenues has grown at a 5.9% compound annual growth rate (CAGR), from $2.33B to $2.92B.
What does vision care — total revenues mean?
Measures the gross inflow of economic benefits from the sale of contact lenses and ocular health products within the Vision Care segment. This is the primary indicator of the segment's market demand and competitive strength. Growth in this metric demonstrates the successful execution of product commercialization and market penetration strategies.

Ask your AI about Bausch + Lomb's vision care — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude